17
Feb
2009
Posted in I - Series A, Q - 1Q09, R - WEST, X - Device (Diagnostic), X - Influenza, XX - CA
HX Diagnostics (Emeryville, CA) an early-stage diagnostics company developing seasonal and pandemic influenza assays, closed a $3.1M Series A financing. Participants include Kleiner Perkins Caufield & Byers, Nanogen and Xiamen YST Biotech.